Please login or register first to view this content.
Oncology Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi’s sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
NEWS & FEATURES
USPSTF Finds Evidence Lacking for Vitamin D Screening
Two-Drug Combo Superior to Sunitinib as First-Line Therapy for Advanced RCC
FDA: Efficacy, Safety Concerns With Breast Cancer Combo Therapy
FDA Approves Radioactive Diagnostic Agent Detectnet
Gavreto Approved for Metastatic RET Fusion-Positive NSCLC
Antihypertensive Drugs and Cancer Risk: Is There a Link?
Oral AML Therapy Onureg Gets FDA Approval
FDA Approves Blood-Based Test as Companion Diagnostic for Multiple Cancer Drugs
Tepotinib Gets Priority Review for Metastatic NSCLC With METex14 Skipping Mutation
Daratumumab Combo Approved for Relapsed/Refractory Multiple Myeloma
FDA: Small Risk of Skin Cancer With Hydrochlorothiazide Use
Guidance Issued for Genetic Testing in Prostate Cancer
Gadavist Imaging Bulk Package Approved for Multi-Patient Dosing
No Cap on Damages in a Medical Battery Case, Says CA Court
Trial Assessing Atezolizumab in Triple-Negative Breast Cancer Misses End Point
Blenrep Approved for Relapsed/Refractory Multiple Myeloma
Monjuvi Approved for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Tecentriq Plus Cotellic and Zelboraf Approved for Advanced Melanoma
